|Day Low/High||26.70 / 27.20|
|52 Wk Low/High||10.65 / 21.91|
In recent trading, shares of Spectranetics Corp. have crossed above the average analyst 12-month target price of $29.00, changing hands for $29.12/share.
Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Spectranetics Corp. , where a total volume of 3,266 contracts has been traded thus far today, a contract volume which is representative of approximately 326,600 underlying shares (given that every 1 contract represents 100 underlying shares).
The most recent short interest data has been released for the 08/15/2016 settlement date, which shows a 1,009,629 share decrease in total short interest for Spectranetics Corp. , to 4,736,778, a decrease of 17.57% since 07/29/2016.
The low-dose drug-coated balloon significantly outperformed standard angioplasty and delivered top-tier outcomes
TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,300 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: AMH, ASC, CLF, CTRL, DSPG, EQS, HSNI, MOG.B, QADB, SLM, SPNC, VNO Downgrades: ARE, L, TLF Initiations: CNXC, GKOS, UFAB Read on to get TheStreet Quant Ratings' detailed report:
In recent trading, shares of Spectranetics Corp. have crossed above the average analyst 12-month target price of $21.80, changing hands for $21.95/share.
Investors eyeing a purchase of Spectranetics Corp. stock, but tentative about paying the going market price of $20.56/share, might benefit from considering selling puts among the alternative strategies at their disposal.
Trade-Ideas LLC identified Spectranetics (SPNC) as a strong on high relative volume candidate